Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCMA-Directed MRD Detection as a Predictor of Relapse after BCMA CAR T in Multiple Myeloma.
Rashid A, Wesson W, Abdallah AO, Snyder J, Venkatesh P, Mushtaq MU, Shune L, Witek MA, McGuirk JP, Soper SA, Cui W, Ahmed N. Rashid A, et al. Among authors: mushtaq mu. Clin Lymphoma Myeloma Leuk. 2024 Oct 11:S2152-2650(24)02364-4. doi: 10.1016/j.clml.2024.10.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39516088
Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review.
Shahzad M, Khan MA, Amin MK, Sarfraz Z, Zulfiqar F, Qasim H, Bansal R, Brownback K, Ahmed N, Abhyankar SH, McGuirk JP, Singh AK, Mushtaq MU. Shahzad M, et al. Among authors: mushtaq mu. Transpl Immunol. 2024 Dec;87:102135. doi: 10.1016/j.trim.2024.102135. Epub 2024 Oct 4. Transpl Immunol. 2024. PMID: 39368752 Free article. Review.
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma.
Wesson W, Dima D, Suleman N, Saif MSI, Tabak C, Logan E, Davis JA, McGann M, Furqan F, Mohan M, Rashid A, Abdallah AO, Ullah F, Shune L, Mushtaq MU, Raza S, McGuirk J, Hamadani M, Anwer F, Hashmi H, Ahmed N. Wesson W, et al. Among authors: mushtaq mu. Transplant Cell Ther. 2024 Sep;30(9):876-884. doi: 10.1016/j.jtct.2024.06.012. Epub 2024 Jun 11. Transplant Cell Ther. 2024. PMID: 38871056 Free article.
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
Shahzad M, Amin MK, Bellman P, Al-Ramahi J, Noor J, Vyas A, Mahmoudjafari Z, McGuirk M, DeJarnette S, Ahmed N, Abdallah AO, Shune L, Singh AK, McGuirk JP, Abhyankar S, Mushtaq MU. Shahzad M, et al. Among authors: mushtaq mu. Transfusion. 2024 Aug;64(8):1402-1406. doi: 10.1111/trf.17909. Epub 2024 Jun 7. Transfusion. 2024. PMID: 38847196
TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians.
Atallah R, Ahmed N, Ayoobkhan F, Saif MSI, Logan E, Shrestha A, Anwer F, Mahmoudjafari Z, Mushtaq MU, Hashmi H, Ganguly S, McGuirk J, Shebli A, Abdallah AO, Banerjee R, Alkharabsheh O. Atallah R, et al. Among authors: mushtaq mu. Transplant Cell Ther. 2024 Sep;30(9):925.e1-925.e6. doi: 10.1016/j.jtct.2024.05.011. Epub 2024 May 18. Transplant Cell Ther. 2024. PMID: 38763416
Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review.
Bellman P, Gonzalez-Lugo JD, Shahzad M, Amin MK, Khalid MF, Suleman N, Ahmed N, Singh AK, Yacoub A, Zhang D, McGuirk JP, Mushtaq MU. Bellman P, et al. Among authors: mushtaq mu. Front Oncol. 2024 Apr 11;14:1383730. doi: 10.3389/fonc.2024.1383730. eCollection 2024. Front Oncol. 2024. PMID: 38665946 Free PMC article.
Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review.
Shahzad M, Khalid MF, Amin MK, Ammad-Ud-Din M, Ilyas U, Mushtaq AH, Butt A, Anwar I, Chaudhary SG, Ahmed N, Shune L, Singh AK, Abhyankar SH, McGuirk JP, Mushtaq MU. Shahzad M, et al. Among authors: mushtaq mu. Hematol Oncol Stem Cell Ther. 2024 Mar 22;17(2):88-94. doi: 10.56875/2589-0646.1118. Hematol Oncol Stem Cell Ther. 2024. PMID: 38560970 Free article.
59 results